Ceribell (CBLL) Cost of Revenue (2023 - 2026)
Ceribell (CBLL) posted Cost of Revenue of $3.4 million for Q1 2026, up 7.35% on a QoQ basis from $3.1 million in Q4 2025, and up 35.75% year-over-year from $2.5 million in Q1 2025.
Ceribell (CBLL) Cost of Revenue (2023 - 2026) Analysis & Trends
Ceribell's Cost of Revenue history runs 4 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- Quarterly Cost of Revenue rose 35.75% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 28.04% YoY) and the FY2025 annual result came in at $10.8 million, up 24.1% from the prior year.
- Cost of Revenue was $3.4 million for Q1 2026 at Ceribell, up from $3.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $3.4 million in Q1 2026 and bottomed at $1.9 million in Q3 2023.
- A 4-year average of $2.4 million and a median of $2.3 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2024 — Cost of Revenue increased 13.95% — and 2025, when it soared 36.8%.
- Ceribell's Cost of Revenue stood at $2.0 million in 2023, then gained by 13.95% to $2.3 million in 2024, then soared by 36.8% to $3.1 million in 2025, then advanced by 7.35% to $3.4 million in 2026.
- Business Quant data shows CBLL's Cost of Revenue at $3.4 million in Q1 2026, $3.1 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Ceribell | 677.56 Mn | 536.38 Mn | 23.12 Mn | 3.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.37 Mn |
| Mar 31, 2026 | 3.37 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Dec 31, 2023 | 2.02 Mn |